[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [@ClearPath100](/creator/twitter/ClearPath100) "@nanalyzetweets $VOYG will see big ramp up once Starlab is active. There is obviously execution risk to the JV which is why market is pricing Voyager as it does - but this is a great time to get in"  [@ClearPath100](/creator/x/ClearPath100) on [X](/post/tweet/1943625993706426397) 2025-07-11 10:58:42 UTC XXX followers, XXX engagements "$VOYG $RKLB $ASTS Seraphim VC Q2. XX report: SpaceTech investment soared to $XXX billion up from $X b in Q1the 2nd largest ever quarterly total. Trailing12month funding reached $XXX b. XX% of capital went into Series B & C"  [@ClearPath100](/creator/x/ClearPath100) on [X](/post/tweet/1945756231991218687) 2025-07-17 08:03:30 UTC XXX followers, XXX engagements "@matan_flank @RNAiAnalyst Significantly mispriced. Many well-known LS/bio-focused funds (e.g. Vestal Point ex Point72 founding partner) have already built up meaningful positions in $QURE"  [@ClearPath100](/creator/x/ClearPath100) on [X](/post/tweet/1943295510296588422) 2025-07-10 13:05:28 UTC XXX followers, XXX engagements "$XBI $QURE #biotech Ryan Wilder's (ex Point72 PM) Vestal Point Capital yesterday disclosed a XXX% position in UniQure. Strong vote of confidence from a luminary in biotech investments. FDA update on AMT-130 expected shortly. Guggenheim says "binary event with 100%+ upside.""  [@ClearPath100](/creator/x/ClearPath100) on [X](/post/tweet/1923240655326720114) 2025-05-16 04:54:38 UTC XXX followers, 2534 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@ClearPath100
"@nanalyzetweets $VOYG will see big ramp up once Starlab is active. There is obviously execution risk to the JV which is why market is pricing Voyager as it does - but this is a great time to get in" @ClearPath100 on X 2025-07-11 10:58:42 UTC XXX followers, XXX engagements
"$VOYG $RKLB $ASTS Seraphim VC Q2. XX report: SpaceTech investment soared to $XXX billion up from $X b in Q1the 2nd largest ever quarterly total. Trailing12month funding reached $XXX b. XX% of capital went into Series B & C" @ClearPath100 on X 2025-07-17 08:03:30 UTC XXX followers, XXX engagements
"@matan_flank @RNAiAnalyst Significantly mispriced. Many well-known LS/bio-focused funds (e.g. Vestal Point ex Point72 founding partner) have already built up meaningful positions in $QURE" @ClearPath100 on X 2025-07-10 13:05:28 UTC XXX followers, XXX engagements
"$XBI $QURE #biotech Ryan Wilder's (ex Point72 PM) Vestal Point Capital yesterday disclosed a XXX% position in UniQure. Strong vote of confidence from a luminary in biotech investments. FDA update on AMT-130 expected shortly. Guggenheim says "binary event with 100%+ upside."" @ClearPath100 on X 2025-05-16 04:54:38 UTC XXX followers, 2534 engagements
/creator/twitter::1896831415054221312/posts